RegulatorMarket Quality Studies2024

WHO: at least 1 in 10 medicines in low- and middle-income countries is substandard or falsified

The WHO estimates at least 1 in 10 medicines in low- and middle-income countries is substandard or falsified.

WHO: at least 1 in 10 medicines in low- and middle-income countries is substandard or falsified
Key findings
  • WHO estimates at least 1 in 10 medicines in low/middle-income countries is substandard or falsified
  • Substandard = fails quality specs (poor manufacturing/QC); falsified = deliberately misrepresents identity, composition, or source
  • About US$30.5 billion/year spent on such products
  • Often sold online or in informal markets; may contain no active, wrong active, or wrong amount

The World Health Organization's December 3, 2024 fact sheet on substandard and falsified medical products gives the scale of the problem and, usefully, a precise vocabulary.

The WHO draws a clear line between two failures. A substandard product is one that fails to meet its quality specifications — usually because of poor manufacturing or poor quality control. A falsified product is one that deliberately misrepresents its identity, composition, or source. The first is a failure of process; the second is a failure of honesty.

The estimated scale is large: about US$30.5 billion is spent each year on these products. They are most often sold online or in informal markets. A falsified product may contain no active ingredient, the wrong active ingredient, or the right one in the wrong amount.

The estimate — at least one in ten medicines in low- and middle-income countries — is a market-quality figure, not a single-product guarantee. But the mechanism it describes is universal: when there is no independent verification of what is in a vial, both kinds of failure can pass undetected. A label can be wrong by accident (substandard) or by design (falsified), and the buyer cannot tell the difference from the label alone.

That is the case for testing the sample rather than trusting the label. Identity testing catches the wrong molecule; content testing catches the wrong amount; purity and safety testing catch the rest. Read together, they are what separates a result from a claim.

WHO fact sheet, Substandard and falsified medical products, December 3, 2024.

Educational information only. Not medical advice. USA Prime Labs tests research materials for research use only; nothing here is intended for human or veterinary use. Talk to a licensed health care provider about any medical decision.
Related articles
USA Prime Labs
USAPRIME LABS
We test the research before you do

We test the research before you do. Identity, purity, content, endotoxin, metals, sterility — verified on one certificate you can check by QR.

All testing is performed on research materials for research use only. Not for human consumption. Results describe the sample as received and do not constitute medical, clinical, or safety advice.

© 2026 USA Prime Labs. Research use only — not for human consumption.Part of the USA Prime family.